$TORC ResTORbio has $117 million in cash and liquidatable investments, which executives estimate will support the company through 2020. The company expects to release data from its mid-stage Parkinson’s trial in mid-2020.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.